Biogen Idec’s scientists have a vision for regenerative medicine, and it has nothing to do with what’s been written and said about embryonic stem cells.

Deep in Biogen’s pipeline, on the verge of entering clinical trials, are a pair of regenerative medicines that the company hopes will become trailblazers in the world of neurological diseases. [...]
Click here to play

The global cleantech industry stayed on a bull run despite a shaky economy in 2008, but the momentum is bound to slow down this year. That was the key finding from a report released yesterday by Portland, OR-based Clean Edge, a consulting firm.

The three major clean energy sectors—solar photovoltaics, wind power, and biofuels—saw their combined [...]
Click here to play

Focus groups are such a standard part of our market-driven culture that they’ve long since become the subject of parody. Decision-makers are seen as being afraid to act without consulting them; surely, no political party would pick a candidate, no legislator would introduce a big policy initiative, and no movie studio would green-light a big-budget [...]
Click here to play

Qualcomm said today the Korean Fair Trade Commission has made allegations about “the lawfulness of certain business practices.” The company says the allegations, set forth in a case examiner’s report, relate to Qualcomm’s integration of multimedia technologies into its chipsets, which are widely used in cell phones, along with “rebates and discounts provided to its [...]
Click here to play

Entrepreneur resource site Seattle 2.0 has announced it is hosting a startup awards ceremony on May 7 at the Pacific Science Center in Seattle. Nominations are open from now until March 25 in 10 categories including best startup, best venture capitalist, best angel investor, and best startup technologist. Finalists will be selected by a panel [...]
Click here to play

The Obama campaign, and subsequently his administration, had been hinting for a long time that it would allow researchers to use federal funds to study human embryonic stem cell “lines” which had, under the policies of President Bush, been legal to study only with private funding. Considering the relatively small number of scientists [...]
Click here to play

Enclarity, a healthcare IT company based in Aliso Viejo, CA, announced today it has closed a $5.5 million Series C round led by Bellevue, WA-based Ignition Partners and Boston, MA-based Bain Capital Ventures. The funds will be used for R&D and product development. Enclarity makes software that helps companies manage healthcare provider information and records.
Click here to play

A survey released today by Microsoft (NASDAQ: MSFT) says San Diego is the best midsize city in the United States for remote working. The nationwide survey commissioned by the Redmond, WA, software giant found that U.S. employers generally support remote-working programs, although just 39.4 percent have a policy that details how their employees can [...]
Click here to play

Seahorse Bioscience, a North Billerica, MA-based maker of instruments for studying mitochondrial function in cells from people with various health problems, announced yesterday that it has acquired BioProcessors Corp., a Woburn, MA, company that makes automated cell-culture equipment for pharmaceutical research. Seahorse didn’t say how much it paid for BioProcessors, but it did reveal that [...]
Click here to play

[Updated at 2:30 pm with additional commentary. See details below]

After President Barack Obama signed a new executive order yesterday that clears the way to resume federal funding for stem cell research, we asked some local Xconomists and other biotech leaders for their reaction. The president’s order reversed eight years of federal funding restrictions imposed by [...]
Click here to play